Tychan is a clinical-stage biotechnology company focused on bringing life-saving treatments to those in need through disruptive technologies. We seek to reduce the development timeline of therapeutics leading to clinical application - a major unmet need in the context of infectious diseases. Our technology platform integrates convergent analytics with innovative manufacturing processes to enable rapid production of safe and effective biologics for human trials. The name Tychan (pronounced Tyk-AN), is derived from Tyche, the Greek goddess who governs the fortune and prosperity of a city and 安 (ān), meaning peace in Mandarin. We believe this integrated approach will enable us to respond to emerging infections during and not after epidemics.